Sanquin Diagnostic Services

Foundation date

01/01/2017

Sector

#Biotechnology / R&D Services

Subsector

Sanquin Health Solutions represents the private/ commercial domain of Sanquin, responsible for all commercial activities serving the life sciences & health industry.

We are active in four core areas: Hematology, Immunology, Oncology and Transfusion Medicine with a strength in discovery/ early development.

The value SHS brings exceeds a standard CRO; with over 200 scientists we develop new technologies and assets for the LS&H industry, moreover, have access to the clinic, patient data and biomaterial (being able to better understand MoA and develop critical biomarkers).

We welcome LS&H companies to become a resident in our HID campus growing a strong ecosystem with over 120.000sqm in lab/office space and access to knowledge and platform technologies.

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023